Lantern Pharma Inc. (LTRN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lantern Pharma Inc.

    NASDAQ: LTRN · Real-Time Price · USD
    4.31
    0.11 (2.62%)
    At close: Sep 05, 2025, 3:59 PM
    4.31
    0.00%
    After-hours: Sep 05, 2025, 04:10 PM EDT

    Lantern Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 190.49K 174.84K 154.68K 97.42K
    Gross Profit
    		 -190.49K -174.84K -154.68K -97.42K
    Operating Income
    		 -22.22M -17.88M -14.43M -12.59M
    Interest Income
    		 742.36K 765.39K 204.35K 67.93K
    Pretax Income
    		 -20.78M -15.96M -14.26M -12.36M
    Net Income
    		 -20.78M -15.96M -14.26M -12.36M
    Selling & General & Admin
    		 6.09M 5.98M 5.83M 5.02M
    Research & Development
    		 16.13M 11.89M 8.6M 7.57M
    Other Expenses
    		 -190.49K -174.84K n/a n/a
    Operating Expenses
    		 22.03M 17.7M 14.43M 12.59M
    Interest Expense
    		 n/a n/a 204.35K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -22.22M 17.88M 14.43M 12.59M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 10.76M 10.84M 10.85M 10.9M
    Shares Outstanding (Diluted)
    		 10.76M 10.84M 10.85M 10.9M
    EPS (Basic)
    		 -1.93K -1.47 -1.31 -1.13
    EPS (Diluted)
    		 -1.93K -1.47 -1.31 -1.13
    EBITDA
    		 -20.59M -15.79M -14.42M -12.27M
    EBIT
    		 -20.78M -15.96M -14.26M -12.36M
    Depreciation & Amortization
    		 190.49K 174.84K 10.08K 97.42K

    Add to Watchlist